Clinical Trial Update: Abiraterone Acetate Trial in African American Prostate Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of abiraterone acetate in African American prostate cancer patients was terminated; results were posted in May 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zytiga (abiraterone acetate)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-05-12